Moderna closed a five-year term loan facility for up to $1.5 billion of capital from Ares Management Credit Funds (Ares) to increase flexibility. The non-dilutive debt financing consists of three ...

At the 2025 Veeva Commercial Summit Europe, experts touted the benefits of AI but stressed the importance of data and ...

Moderna's chief technical operations officer explains why now is the right time to take full control of the company's ...

Explore the role of AI in drug discovery and how automation enhances precision and speed in modern scientific research.

The state's economic development undersecretary is about to join Flagship Pioneering as its vice president of operations, ...

Moderna ( ($MRNA) ) just unveiled an update. On November 19, 2025, Moderna, Inc. entered into a Credit and Guaranty Agreement providing a $1.5 ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that ...